Recent Finacing
Recent Raise
Pluristyx develops gene-edited, clinical-grade iPSC lines (PluriBank), a panCELLa engineering platform, and cGMP-compatible cell line engineering tools, services, and licensing for cell therapy development.
Focus Areas
Recent Investors
Funding round
Investor
See the team members at Pluristyx.
